Abstract
EWSR1-SMAD3 fibroblastic tumour is a recently described soft tissue lesion. To date, eight cases have been reported, all sited in superficial soft tissue, typically occurring in the hands and feet with a tendency for local recurrence if incompletely excised. No metastatic spread has been reported, and hence, these tumours are currently considered benign. Herein, we present the radiological and histological features of the first reported occurrence of this entity in bone: a 44-year-old man with a tumour in the right tibia, treated with en bloc resection and showing no signs of relapse at 7 years. This tumour should be added to the differential diagnosis of bone lesions which harbour EWSR1 gene rearrangement.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Baumhoer D, Amary F, Flanagan AM. An update of molecular pathology of bone tumors. Lessons learned from investigating samples by next generation sequencing. Genes Chromosomes Cancer. 2019;58(2):88–99.
Italiano A, Sung YS, Zhang L, et al. High prevalence of CIC fusion with double-homeobox (DUX4) transcription factors in EWSR1-negative undifferentiated small blue round cell sarcomas. Genes Chromosomes Cancer. 2012;51(3):207–18.
Thway K, Fisher C. Mesenchymal tumors with EWSR1 gene rearrangements. Surg Pathol Clin. 2019;12(1):165–90.
Kao Y-C, Flucke U, Eijkelenboom A, et al. Novel EWSR1-SMAD3 gene fusions in a group of acral fibroblastic spindle cell neoplasms. Am J Surg Pathol. 2018;42(4):522–8.
Antonescu CR, Suurmeijer AJH. EWSR1-SMAD3-positive fibroblastic tumour (emerging). In: WHO classification of tumours EB, ed. WHO Classification of tumours soft tissue and bone tumours. Fifth Edition ed. Lyon (France): IARC; 2020:76–77.
Caulfield M, Davies J, Dennys M, et al. The National Genomics Research and Healthcare Knowledgebase, 2019.
Amary MF, Berisha F, Bernardi Fdel C, et al. Detection of SS18-SSX fusion transcripts in formalin-fixed paraffin-embedded neoplasms: analysis of conventional RT-PCR, qRT-PCR and dual color FISH as diagnostic tools for synovial sarcoma. Mod Pathol. 2007;20(4):482–96.
Zhao L, Sun M, Lao IW, Yu L, Wang J. EWSR1-SMAD3 positive fibroblastic tumor. Exp Mol Pathol. 2019;110:104291.
Michal M, Berry RS, Rubin BP, et al. EWSR1-SMAD3-rearranged fibroblastic tumor: an emerging entity in an increasingly more complex group of fibroblastic/myofibroblastic neoplasms. Am J Surg Pathol. 2018;42(10):1325–33.
Hashimoto N, Ueda T, Joyama S, et al. Extraskeletal mesenchymal chondrosarcoma: an imaging review of ten new patients. Skelet Radiol. 2005;34(12):785–92.
MacSweeney F, Darby A, Saifuddin A. Dedifferentiated chondrosarcoma of the appendicular skeleton: MRI-pathological correlation. Skelet Radiol. 2003;32(12):671–8.
Bilodeau EA, Weinreb I, Antonescu CR, et al. Clear cell odontogenic carcinomas show EWSR1 rearrangements: a novel finding and a biological link to salivary clear cell carcinomas. Am J Surg Pathol. 2013;37(7):1001–5.
Massagué J. TGFβ signalling in context. Nat Rev Mol Cell Biol. 2012;13(10):616–30.
Acknowledgements
This research was made possible through access to the data and findings generated by the 100,000 Genomes Project; http://www.genomicsengland.co.uk.
Funding
Funding was provided by Sarcoma UK, The Tom Prince Cancer Trust and The Bone Cancer Research Trust.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
De Noon, S., Flanagan, A.M., Tirabosco, R. et al. EWSR1-SMAD3 fibroblastic tumour of bone: expanding the clinical spectrum. Skeletal Radiol 50, 445–450 (2021). https://doi.org/10.1007/s00256-020-03563-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00256-020-03563-0